← Leaderboards
Michael J Econs
Indiana Univ-Purdue Univ At Indianapolis
$17,934,951
Attributed
$17,934,951
Total exposure
23
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,008,318 · 24
By mechanism
P01$21,295,064 · 2
R01$11,389,436 · 6
P30$1,962,305 · 1
R21$1,886,299 · 5
K24$432,820 · 1
M01$42,394 · 9
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Edward F Srour$12,800,260
- Hal E. Broxmeyer$36,408,829
- David A Williams$57,290,422
- Kenneth W Dunn$10,198,541
- Randall L Duncan$5,210,242
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeClinical ResearchGenesBone DensityAffectHuman SubjectGenotypeBoneFamilySamplingMutationFamily GeneticsMolecular CloningSeverity Of IllnessAnimal ModelOsteoclastsAdultAutosomal Dominant TraitImpairmentFractureMouse ModelBaseKidneyMissense Mutation
Grant awards (98)
Autosomal Dominant Osteopetrosis: A Natural History Study$192,231
R01 · FY2025 · AR · contact PI
Autosomal Dominant Osteopetrosis: A Natural History Study$255,022
R01 · FY2024 · AR · contact PI
The Natural History of Autosomal Dominant Osteopetrosis Type 2$206,610
R01 · FY2022 · AR · contact PI
The role of Tmem263 in regulation of bone mass and strength$172,607
R21 · FY2022 · AR · contact PI
Methodologic Core$389,586
P30 · FY2021 · AR · contact PI
Mechanistic and Therapeutic Studies of Autosomal Dominant Osteopetrosis$336,105
R01 · FY2021 · AR · contact PI
Mechanistic Ancillary Study to the Natural History Study of ADO2 to Determine Clinical Severity$231,220
R21 · FY2021 · AR · contact PI
The role of Tmem263 in regulation of bone mass and strength$209,220
R21 · FY2021 · AR · contact PI
The Natural History of Autosomal Dominant Osteopetrosis Type 2$206,211
R01 · FY2021 · AR · contact PI
Methodologic Core$389,586
P30 · FY2020 · AR · contact PI
Mechanistic and Therapeutic Studies of Autosomal Dominant Osteopetrosis$346,500
R01 · FY2020 · AR · contact PI
The Natural History of Autosomal Dominant Osteopetrosis Type 2$219,429
R01 · FY2020 · AR · contact PI
Methodologic Core$389,586
P30 · FY2019 · AR · contact PI
Mechanistic and Therapeutic Studies of Autosomal Dominant Osteopetrosis$346,500
R01 · FY2019 · AR · contact PI
Methodologic Core$389,586
P30 · FY2018 · AR · contact PI
Mechanistic and Therapeutic Studies of Autosomal Dominant Osteopetrosis$346,500
R01 · FY2018 · AR · contact PI
Methodologic Core$403,961
P30 · FY2017 · AR · contact PI
Mechanistic and Therapeutic Studies of Autosomal Dominant Osteopetrosis$345,125
R01 · FY2017 · AR · contact PI
Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project$170,618
R21 · FY2017 · AR · contact PI
Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project$199,813
R21 · FY2016 · AR · contact PI
Identification of genes that affect peak BMD in men and women$610,028
R01 · FY2015 · AG · contact PI
Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project$167,755
R21 · FY2015 · AR · contact PI
Identification of genes that affect peak BMD in men and women$571,922
R01 · FY2014 · AG · contact PI
Clinical and Genetic Analysis of ADHR$325,987
R01 · FY2014 · AR · contact PI
Identification of genes that affect peak BMD in men and women$555,603
R01 · FY2013 · AG · contact PI
Clinical and Genetic Analysis of ADHR$316,008
R01 · FY2013 · AR · contact PI
Identification of genes that affect peak BMD in men and women$576,191
R01 · FY2012 · AG · contact PI
Clinical and Genetic Analysis of ADHR$332,640
R01 · FY2012 · AR · contact PI
The Effects of Iron Status on FGF23 Metabolism and Bone Health.$173,250
R21 · FY2012 · AR · contact PI
Identification of genes that affect peak BMD in men and women$592,750
R01 · FY2011 · AG · contact PI
Clinical and Genetic Analysis of ADHR$332,640
R01 · FY2011 · AR · contact PI
The Effects of Iron Status on FGF23 Metabolism and Bone Health.$207,900
R21 · FY2011 · AR · contact PI
Clinical and Genetic Analysis of ADHR$346,500
R01 · FY2010 · AR · contact PI
Genetic Determinants of Bone Fragility$115,500
P01 · FY2010 · AG · contact PI
Genetic Determinants of Bone Fragility$1,862,271
P01 · FY2009 · AG · contact PI
GENETIC DETERMINANTS OF PEAK BMD IN MEN & WOMEN$457,620
P01 · FY2009 · AG · contact PI
Genetic Determinants of Bone Fragility$123,200
P01 · FY2009 · AG · contact PI
Genetic Determinants of Bone Fragility$1,808,257
P01 · FY2008 · AG · contact PI
GENETIC DETERMINANTS OF PEAK BMD IN MEN & WOMEN$444,291
P01 · FY2008 · AG · contact PI
CLINICAL AND GENETIC ANALYSIS OF ADHR$300,491
R01 · FY2008 · AR · contact PI
CREATION OF THE AD02 MOUSE$191,053
R21 · FY2008 · AR · contact PI
THE CLINICAL AND GENETIC ANALYSIS OF AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS$29
M01 · FY2008 · RR · contact PI
Genetic Determinants of Bone Fragility$1,805,358
P01 · FY2007 · AG · contact PI
GENETIC DETERMINANTS OF PEAK BMD IN MEN & WOMEN$441,399
P01 · FY2007 · AG · contact PI
CLINICAL AND GENETIC ANALYSIS OF ADHR$306,837
R01 · FY2007 · AR · contact PI
CREATION OF THE AD02 MOUSE$162,863
R21 · FY2007 · AR · contact PI
THE CLINICAL AND GENETIC ANALYSIS OF AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS$341
M01 · FY2007 · RR · contact PI
Genetic Determinants of Bone Fragility$1,799,108
P01 · FY2006 · AG · contact PI
GENETIC DETERMINANTS OF PEAK BMD IN MEN & WOMEN$443,000
P01 · FY2006 · AG · contact PI
CLINICAL AND GENETIC ANALYSIS OF ADHR$316,214
R01 · FY2006 · AR · contact PI
THE CLINICAL AND GENETIC ANALYSIS OF AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS$606
M01 · FY2006 · RR · contact PI
Genetic Determinants of Bone Fragility$1,846,347
P01 · FY2005 · AG
GENETIC DETERMINANTS OF PEAK BMD IN MEN &WOMEN$435,387
P01 · FY2005 · AG
CLINICAL AND GENETIC ANALYSIS OF ADHR$329,802
R01 · FY2005 · AR
GENETIC AND CLINICAL STUDIES OF AD02$307,479
R01 · FY2005 · AR
THE CLINICAL AND GENETIC ANALYSIS OF AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS$1,105
M01 · FY2005 · RR
INTRAVENOUS ZOLEDRONIC ACID IN PREVENTING SUBSEQUENT OSTEOPOROTIC FRACTURES$221
M01 · FY2005 · RR
CLINICAL AND GENETIC STUDIES OF OSTEOPETROSIS$221
M01 · FY2005 · RR
GENETIC DETERMINANTS OF BONE FRAGILITY$2,019,912
P01 · FY2004 · AG
GENETIC AND CLINICAL STUDIES OF AD02$354,510
R01 · FY2004 · AR
CLINICAL AND GENETIC ANALYSIS OF ADHR$331,100
R01 · FY2004 · AR
Genetic Determinants of Peak in Bone Mass in Women$34,638
M01 · FY2004 · RR
The Clinical and Genetic Analysis of Autosomal Dominant Hypophosphatemic Rickets$2,990
M01 · FY2004 · RR
Family Studies of Bone Mass$2,243
M01 · FY2004 · RR
GENETIC DETERMINANTS OF BONE FRAGILITY$2,066,587
P01 · FY2003 · AG
GENETIC AND CLINICAL STUDIES OF AD02$359,348
R01 · FY2003 · AR
CLINICAL AND GENETIC ANALYSIS OF ADHR$277,135
R01 · FY2003 · AR
GENETIC DETERMINANTS OF METABOLIC BONE DISEASE$108,205
K24 · FY2003 · AR
GENETIC DETERMINANTS OF BONE FRAGILITY$102,440
P01 · FY2003 · AG
GENETIC DETERMINANTS OF BONE FRAGILITY$1,936,398
P01 · FY2002 · AG
GENETIC AND CLINICAL STUDIES OF AD02$359,424
R01 · FY2002 · AR
CLINICAL AND GENETIC ANALYSIS OF ADHR$269,063
R01 · FY2002 · AR
GENETIC DETERMINANTS OF METABOLIC BONE DISEASE$108,205
K24 · FY2002 · AR
GENETIC DETERMINANTS OF PEAK BMD IN WOMEN$0
P01 · FY2002 · AG
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2002 · RR
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2002 · RR
GENETIC DETERMINANTS OF BONE FRAGILITY$1,750,746
P01 · FY2001 · AG
CLINICAL AND GENETIC ANALYSIS OF ADHR$261,225
R01 · FY2001 · AR
GENETIC DETERMINANTS OF METABOLIC BONE DISEASE$108,205
K24 · FY2001 · AR
GENETIC DETERMINANTS OF BONE FRAGILITY$4,060
P01 · FY2001 · AG
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2001 · RR
GENETIC DETERMINANTS OF PEAK BMD IN WOMEN$0
P01 · FY2001 · AG
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2001 · RR
GENETIC DETERMINANTS OF PEAK BMD IN WOMEN$0
P01 · FY2001 · AG
GENETIC DETERMINANTS OF BONE FRAGILITY$1,833,183
P01 · FY2000 · AG
CLINICAL AND GENETIC ANALYSIS OF ADHR$256,306
R01 · FY2000 · AR
GENETIC DETERMINANTS OF METABOLIC BONE DISEASE$108,205
K24 · FY2000 · AR
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2000 · RR
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2000 · RR
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2000 · RR
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2000 · RR
GENETIC DETERMINANTS OF PEAK BMD IN WOMEN$0
P01 · FY2000 · AG
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2000 · RR
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2000 · RR
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2000 · RR
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2000 · RR
GENETIC ANALYSIS OF HYPOPHOSPHATEMIC RICKETS$0
M01 · FY2000 · RR
CLINICAL &GENETIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS$0
M01 · FY2000 · RR